Denosumab-induced hypophosphataemia in a case of normocalcaemic primary hyperparathyroidism
Intern Med J
.
2017 Aug;47(8):974-975.
doi: 10.1111/imj.13508.
Authors
Ilze Konrade
1
,
Gita Dambrova
1
,
Maija Dambrova
2
Affiliations
1
Department of Endocrinology, Riga East Clinical University Hospital, Riga Stradins University, Riga, Latvia.
2
Laboratory of Pharmaceutical Pharmacology, Latvian Institute of Organic Synthesis, Riga, Latvia.
PMID:
28782221
DOI:
10.1111/imj.13508
No abstract available
Publication types
Letter
Comment
MeSH terms
Calcium
Denosumab*
Humans
Hyperparathyroidism
Hyperparathyroidism, Primary*
Hypophosphatemia
Substances
Denosumab
Calcium